Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsVentura County MuGard Prior Auth Policy | OpenPaye…
    Ask Trek AI about this page
    CurrentVentura County Health Care PlanPolicy N/A

    MuGard (carbomer, glycerin, and polysorbate) Coverage Criteria

    Customize your policy alerts

    Sign up for all venturacountyhealthcareplan policy alerts

    Know when venturacountyhealthcareplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs authorization and use of MuGard and equivalent brand products for managing oral mucosal pain, irritation, ulcers, inflammation, and related oral lesions.

    Policy Summary
    PayerVentura County Health Care Plan
    PolicyMuGard (carbomer, glycerin, and polysorbate) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeRevised
    Effective DateJan 28, 2014
    Last ReviewFeb 20, 2026
    Next Review DateN/A
    Key ActionRequest authorization only when MuGard is used to manage a covered oral condition.
    SourceLink
    POLICY UPDATE CHANGES

    The description, authorization, dosing, and precaution sections were updated.

    The product description and references were updated.

    5 mLStandard rinse volume
    4–6 times dailyTypical frequency
    10 mLMaximum rinse volume
    1 hourPost-rinse interval
    Children

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Use not recommended for

    Covered Uses and Restrictions

    Authorized indications

    Covered when used for management of at least one of the following conditions:

    Covered indications

    • Chemotherapy- or radiation-related mucositis/stomatitis: Oral mucositis or stomatitis resulting from chemotherapy or radiation therapy.
    • Oral lesions and inflammation: Oral lesions, periodontal inflammation, or gingival inflammation.
    • Post-procedural wounds or lesions: Tooth extractions or wounds or lesions due to oral surgery.
    • Traumatic ulcers or abrasions caused by braces, ill-fitting dentures, or disease.
    • Aphthous ulcers: Diffuse aphthous ulcers.
    • Pharyngeal symptoms: Sore throat or pharyngitis.

    Use is not recommended for children.

    Authorization and Use Requirements

    Prior Authorization

    Covered Indication Required

    Authorization requires management of covered oral mucosal pain, irritation, lesions, or related conditions, including oral mucositis/stomatitis from chemotherapy or radiation therapy; oral lesions; periodontal or gingival inflammation; tooth extractions; oral-surgery wounds or lesions; traumatic ulcers or abrasions from braces or ill-fitting dentures or disease; diffuse aphthous ulcers; and sore throat/pharyngitis.

    Denial Risk

    Use Outside Covered Indications

    Requests outside the listed covered indications are not supported and may be denied.

    Note

    Pediatric Use

    Product Overview

    MuGard is an oral mucosal barrier gel that forms a protective coating over the oral mucosa. The policy supports its use to manage oral mucosal pain and protect irritated or injured oral tissue associated with chemotherapy- or radiation-related mucositis, oral surgery, traumatic injury, aphthous ulcers, pharyngitis, and other covered oral conditions.

    Product Definition

    MuGard
    ProductMuGard
    Product typeOral mucosal barrier gel
    Primary functionForms a protective coating over the oral mucosa

    Initial Authorization

    Initial authorization

    Initial authorization is supported when the requested product is used for at least one covered oral condition.

    Covered initial-use indication: The patient has an eligible oral mucositis, stomatitis, lesion, inflammatory, ulcerative, traumatic, surgical, or pharyngeal condition described in the policy.

    The requested product must be used to manage oral mucosal pain and protect against further irritation associated with the covered condition.

    Policy Summary
    PayerVentura County Health Care Plan
    PolicyMuGard (carbomer, glycerin, and polysorbate) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeRevised
    Effective DateJan 28, 2014
    Last ReviewFeb 20, 2026
    Next Review DateN/A
    Key ActionRequest authorization only when MuGard is used to manage a covered oral condition.
    SourceLink
    On This Page
    Covered Uses and RestrictionsAuthorization and Use RequirementsProduct OverviewProduct DefinitionInitial Authorization

    Use in children is not recommended.